Vaccination coverage rates for Diphtheria,Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data |
| |
Authors: | Clarisse Marchal Manon Belhassen Nicole Guiso Flore Jacoud Eric Van Ganse Marie Le Pannerer Robert Cohen Régis Verdier Mathieu Uhart |
| |
Affiliation: | 1. PELyon (Pharmaco Epidemiology Lyon), Lyon, France;2. Independent Expert, Paris, France;3. Respiratory Medicine, Croix Rousse University Hospital, and HESPER 7425, Health Services and Performance Research, University Claude Bernard Lyon 1, Lyon, France;4. Sanofi Pasteur, Lyon, France;5. Université Paris Est, IMRB-GRC GEMINI, Créteil, France;6. Clinical Research Center (CRC), Centre Hospitalier Intercommunal de Créteil, France;7. GPIP, Pediatric Infectious Disease Group, France;8. ACTIV, Pediatric Clinical and Therapeutical Association of the Val de Marne, Saint-Maur des Fossés, France;9. Unité Court Séjour, Petits Nourrissons, Service de Néonatologie, Centre Hospitalier Intercommunal de Créteil, France |
| |
Abstract: | BackgroundMaintaining a high vaccination coverage rate (VCR) throughout the lifetime and complying with the National Immunization Program are essential to optimize the protection of the population. The study objectives were to evaluate the evolution of the VCRs and the compliance with the vaccination visits for the diphtheria, tetanus, poliomyelitis and pertussis boosters in France since the changes implemented in the 2013 National Immunization Program.MethodsCumulative booster VCRs were estimated at all vaccination visits, from 2013 to 2017, among persons eligible for a booster vaccination from a 1/97th random sample of French claims data. Broader age groups around the recommended ages by the vaccination schedule (6, 11–13, 25, 45, 65, 75, 85, 95y) were used: all persons aged 5 to 8, 10 to 15, 21 to 29, 41 to 49, 61 to 69, 71 to 79, 81 to 89 and 91 to 99.ResultsOver the study period, the diphtheria-tetanus-poliomyelitis booster VCRs increased, reaching in 2017: 73.3% at 8 years old, 75.6% at 15 years old, 46.6% at 29 years old, 38.4% at 49 years old, 36.3% at 69 years old, 30.8% at 79 years old, 22.1% at 89 years old and 11.0% at 99 years old. The pertussis VCRs were also increasing at all vaccination visits, in particular at the vaccination visits at 6 and 11–13 years old (from 16.4% to 63.8% and from 50.3% to 61.2%, respectively). Delayed vaccinations were observed at all vaccination visits.ConclusionVCRs for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination increased from 2013 to 2017 while remaining suboptimal across all ages and lower in the adult populations. The analysis also shows that the introduction in 2013 of a pertussis vaccination at 6 years of age was relatively well-established in 2017 while other changes in recommendations were slowly or partially implemented. |
| |
Keywords: | Vaccination coverage rates Claims database Booster vaccines Diphtheria-tetanus-poliomyelitis and pertussis National immunization program ACIP" },{" #name" :" keyword" ," $" :{" id" :" k0035" }," $$" :[{" #name" :" text" ," _" :" Advisory Committee on Immunization Practices Ap" },{" #name" :" keyword" ," $" :{" id" :" k0045" }," $$" :[{" #name" :" text" ," _" :" Pertussis DTaP-IPV" },{" #name" :" keyword" ," $" :{" id" :" k0055" }," $$" :[{" #name" :" text" ," _" :" Diphtheria, Tetanus, Pertussis and Poliomyelitis EGB" },{" #name" :" keyword" ," $" :{" id" :" k0065" }," $$" :[{" #name" :" text" ," _" :" Echantillon Généraliste de Bénéficiaires (1/97th random and representative sample of the French national claims database) ESPS" },{" #name" :" keyword" ," $" :{" id" :" k0075" }," $$" :[{" #name" :" text" ," _" :" Enquêtes Santé et Protection Sociale ICD" },{" #name" :" keyword" ," $" :{" id" :" k0085" }," $$" :[{" #name" :" text" ," _" :" International Classification of Diseases NIP" },{" #name" :" keyword" ," $" :{" id" :" k0105" }," $$" :[{" #name" :" text" ," _" :" National Immunization Program SNDS" },{" #name" :" keyword" ," $" :{" id" :" k0115" }," $$" :[{" #name" :" text" ," _" :" Système National des Données de Santé (French National Health System) Td" },{" #name" :" keyword" ," $" :{" id" :" k0125" }," $$" :[{" #name" :" text" ," _" :" Tetanus and diphtheria, with reduced antigen content for diphtheria toxoid Tdap" },{" #name" :" keyword" ," $" :{" id" :" k0135" }," $$" :[{" #name" :" text" ," _" :" Tetanus, diphtheria and pertussis, with reduced antigen content for diphtheria toxoid and pertussis Tdap-IPV" },{" #name" :" keyword" ," $" :{" id" :" k0145" }," $$" :[{" #name" :" text" ," _" :" Tetanus, diphtheria, pertussis and poliomyelitis, with reduced antigen content for diphtheria toxoid and pertussis Td-IPV" },{" #name" :" keyword" ," $" :{" id" :" k0155" }," $$" :[{" #name" :" text" ," _" :" Tetanus, diphtheria and poliomyelitis, with reduced antigen content for diphtheria toxoid VCR" },{" #name" :" keyword" ," $" :{" id" :" k0165" }," $$" :[{" #name" :" text" ," _" :" Vaccination Coverage Rate |
本文献已被 ScienceDirect 等数据库收录! |
|